BSE Announcements

Date Heading Details
15-Feb-2019 AAR Shyam India Inv. 1. Approval of Unaudited Financial Results of the Company for the quarter and nine Month ended on December 31, 2018 and taking a note on the Limited Review Report provided by the Statutory Auditors of the Company. (Enclosed as Annexure I). 2. The Board has decided that of the two Stock Exchanges where the Equity Shares of the Company are listed i.e. Calcutta Stock Exchange Limited & BSE Limited (BSE), the Company shall make an application for voluntary delisting of its equity shares from Calcutta Stock Exchange Limited (CSE) pursuant to the provision of Regulation 6 & 7 of the SEBI (Delisting of Equity Shares) Regulation, 2009, without giving any exit opportunity to shareholders. After delisting from Calcutta Stock Exchange Limited (CSE), the equity shares of the Company will continue to remain listed on BSE Limited (BSE) having nation-wide trading terminal. 3. Appointment of Mr. Sanyam Tuteja (DIN 0008139915) as Additional Director in the capacity of Whole Time Director (Professional) on the Board of the Company w.e.f. 14.02.2019 4. Appointment of Ms. Reetika Choubey (DIN 08363044) as a Non Executive Independent Director on the Board of the Company w.e.f. 14.02.2019 5. Taken note of Resignation of Mr. Sahib Singh Gusain (DIN:00649786), from the post of Whole Time Director of the Company due to his other commitments, with immediate effect
15-Feb-2019 ACI Infocom inter alia, approved the following:Appointment of Mr. Kalpesh Bhandari (DIN: 03146496), as Additional Independent Director of the Company w.e.f. 08th February 2019.
15-Feb-2019 Ad-Manum Fin. This is to inform you that Mr. Jayanta Nath Choudhury, Director-in-Charge & CEO and Mrs. Dolly Choudhury, Whole-Time-Director of the Company, with reference to their Notice of Resignation dated 01/10/2018, tendered their resignation w.e.f. 15/02/2019 at the Meeting of Board of Directors held on 15/02/2019 and Board of Directors accepted the same.
15-Feb-2019 Alembic Pharma With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Moxifloxacin Ophthalmic Solution USP, 0.5%.
15-Feb-2019 Alka Sec REVISED OUTCOME OF THE BOARD MEETING DATED 14TH FEBRUARY 2019 PLEASE NOTE THE NAME OF THE COMPANIES APPROVED FOR INVESTMENT BY THE BOARD WHERE THE WRONG ENTITIES, THE CORRECT ENTITIES ARE NAMED HEREIN. PLEASE REFER TO THIS OUTCOME FOR THE CORRECT NAMES OF THE INVESTEE COMPANIES. ALL OTHER INFORMATION REGARDING THE RESULT IS CORRECT AND UNCHANGED.
15-Feb-2019 Allied Computer Intl With reference to above subject and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company hereby submit the outcome of the Meeting of Board of Director held on today i.e. 13th February, 2019 at 03:30 p.m. & concluded on 7:00 p.m. 1) Considered, adopted & approved Unaudited Financial Results for the quarter ended on 31st December, 2018 2) The Board accepted and noted the resignation tendered by M/s Mukesh M. Choksi & Co., Chartered Accountants. 3) Appointment of M/s Mohandas & Co., Chartered Accountants to fill up the casual vacancy cause due to resignation of statutory auditor, subject to approval of Shareholder Meeting. 4) Fixed Day, Date and time for EGM to be held on Monday, 11th March, 2019 at 11:00 a.m. and approval of the Draft Notice of EGM. 5) Approval and adoption to Draft notice of EGM. 6) Appointment of Mr. Chirag Jain, Practicing Company Secretary as Scrutinizer for the process of Remote E-voting as well as voting at the EGM.
15-Feb-2019 Ambitious Plasto Ambitious Plastomac Company Ltd has informed BSE about Outcome of Board Meeting held on February 14, 2019.
15-Feb-2019 Amrit Corp Further to our letter dated 05.02.2019, this is to inform you that the Company has on February 14, 2019 completed the dispatch of Postal Ballot Notice dated 05.02.2019 to all the members. Copy of the Postal Ballot Notice alongwith the Postal Ballot Form sent to the members is attached herewith.
15-Feb-2019 Anuh Pharma inter alia, approved the following: 1)Appointment of Dr. Mita Dixit, aged 53 years (DIN:08198165)as an Additonal Director (Non-Executive Independent Women Director) of the company with immediate effect for a period of five years, subject to approval of the shareholders of the Company. 2)Re-appointment of Mr. Bipin N. Shah, aged 69 years (DIN:00083244) Managing Director for a period of 5 consecutive years w.e.f. 1st April,2019 to 31st March, 2024.subject to the approval of the Shareholders of the Company. 3)Re-appointment of Mr. Jasvantlal G. Shah aged 85 years (DIN:00372600) Chairman & Independent Director for the second term of 5 consecutive years w.e.f. 1st April 2019 to 31st March, 2024. subject to the approval of the shareholders of the Company. 4)Re-appointment of Mr. Dilip G.Shah aged 77 years (DIN:01989812) Independent Director for the second of 5 consecutive years w.e.f. 1st April, 2019 to 31st March, 2024. subject to the approval of the Shareholders of the Company. 5)Re-appointment of Mr.Arun. L. Todarwal, aged 61 years (DIN:00020916) Independent Director for the second term of 5 consecutive years w.e.f. 1st April,2019 to 31st March, 2024 subject to the approval of the Shareholders of the Company. 6)Continuation of Directorship of Mr. Lalitkumar P. Shah aged 82 years (DIN:00396345) Non-Executive Director, as a Director of the Company.
15-Feb-2019 Apunka Invest Comml. We are pleased to inform you that 9th/2018-19 Meeting of the Board of Directors of the Apunka Invest Commercial Ltd was held on Thursday, on 14th February, 2019 at 1:00 P.M. at its the Corporate office of the Company situated at 1003 & 1004, 10th Floor (West Side) Lotus Grandeur, Veera Desai Road, Andheri West Mumbai -400053

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested